Back

Prediction of mortality and heart failure admission with the mitraScore after percutaneous mitral valve repair: an external validation study

13 December 2024 (10:27 - 10:39)
Organised by: Logo
Congress Presentation Part of: What's new in valvular heart disease Valvular Heart Disease EACVI Premium Access EuroEcho-Imaging 2024 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Mr Lucas Javier Barreiro Mesa

Reina Sofia University Hospital, Cordoba (Spain)

3 More presentations in this session

Presentation thumbnail
Frequency, course and prognostic yield of valvular heart disease in the general population- Results from the STAAB cohort study
Doctor M. Chen (Wuerzburg, DE)
Abstract Slides Video
Presentation thumbnail
Left ventricular pressure-strain-volume-loop and myocardial work patterns in asymptomatic severe aortic regurgitation with early disease decompensation
Doctor E. de Oliveira (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
Prognostic role of right atrial strain in patients with secondary tricuspid regurgitation: insights from the CARE-TR registry
Doctor L. Lupi (Brescia, IT)
Abstract Slides Video

Access the full session

Session thumbnail
What's new in valvular heart disease
Video

The Event

Event poster

EuroEcho-Imaging 2024

13 December 2024 10:27 CET
You may be interested in
thumbnail
Congress Presentation
MitrAI score: machine learning models to predict mortality at 12, 24, 36 and 48 months in patients with primary and secondary mitral regurgitation treated by transcatheter edge-to-edge repair.
thumbnail
Congress Session
Registries on valvular heart disease
thumbnail
Congress Session
What's new in valvular heart disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources